Opening book details…
About this Medicine article
Safety of lanreotide 120 mg ATG in combination with metformin in patients with advanced well-differentiated gastro-intestinal (GI) or lung carcinoids. A pilot, one-arm, open-label, prospective study: The MetNET-2 trial by De Braud, F.G.M.; Buzzoni, R.; Concas, L.; Femia, D.; Prinzi, N.; Milione, M.; Tamborini, E.; Perrone, F.; Russo, G. Lo; Vernieri, C.; Pulice, I.; Piras, F.; Dinoi, G.; Pusceddu, S. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- De Braud, F.G.M.; Buzzoni, R.; Concas, L.; Femia, D.; Prinzi, N.; Milione, M.; Tamborini, E.; Perrone, F.; Russo, G. Lo; Vernieri, C.; Pulice, I.; Piras, F.; Dinoi, G.; Pusceddu, S.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2016
- Language
- EN
- Field
- Medicine (Health Sciences)